Volume 60, Issue 1, Pages 341-349 (July 2001) Multicenter trial of one HLA-DR–matched or mismatched blood transfusion prior to cadaveric renal transplantation  Christian Hiesse, M.D., Marc Busson, Claude Buisson, Hossein Farahmand, Philippe Bierling, Marc Benbunan, Janine Bedrossian, Philippe Aubert, Denis Glotz, Chantal Loirat, Eric Rondeau, Béatrice Viron, Helène Bleux, Philippe Lang  Kidney International  Volume 60, Issue 1, Pages 341-349 (July 2001) DOI: 10.1046/j.1523-1755.2001.00805.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Five-year kidney graft survival in patients who received a single pre-transplantation blood unit, with matching for one human lymphocyte antigen (HLA)-DR or without HLA-DR matching between recipients and blood donors, and in patients who received no transfusion. Symbols are: ( ) non-transfused patients (N = 36); (– – –) one DR-matched unit transfused patients (N = 31); (····) DR-mismatched unit transfused patients (N = 39). Kidney International 2001 60, 341-349DOI: (10.1046/j.1523-1755.2001.00805.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan–Meier estimates of the occurrence of first rejection during the six-month post-transplant period for the three groups. Symbols are: ( ) non-transfused patients (N = 36); (– – –) one DR-matched unit transfused patients (N = 31); (····) DR-mismatched unit transfused patients (N = 39). Kidney International 2001 60, 341-349DOI: (10.1046/j.1523-1755.2001.00805.x) Copyright © 2001 International Society of Nephrology Terms and Conditions